Ocumetics Technology Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jul '21 Jul 31, 2021
Selling, General & Admin	1.31	1.21	2.05	1	1.1	0.56
Research & Development	1.39	0.85	0.91	0.56	0.24	-
Amortization of Goodwill & Intangibles	-	-	-	0.1	0.1	0.08
Operating Expenses	2.88	2.37	3.56	2.14	2.01	0.65
Operating Income	-2.88	-2.37	-3.56	-2.14	-2.01	-0.65
Interest Expense	-1.32	-0.64	-0.03	-0.03	-0.03	-
Interest & Investment Income	0.01	0.04	-	-	-	-
Currency Exchange Gain (Loss)	-0.03	-0.04	-0.01	-0.01	-0	-
Other Non Operating Income (Expenses)	-0.07	-0.06	-0.04	-	-0.14	-
EBT Excluding Unusual Items	-4.28	-3.06	-3.64	-2.18	-2.17	-0.65
Other Unusual Items	-	-	-	-0.04	-1.37	-
Pretax Income	-4.28	-3.06	-3.64	-2.22	-3.54	-0.65
Income Tax Expense	-0.04	-0.04	-	-	-	-
Net Income	-4.24	-3.02	-3.64	-2.22	-3.54	-0.65
Net Income to Common	-4.24	-3.02	-3.64	-2.22	-3.54	-0.65
Shares Outstanding (Basic)	121	120	115	110	104	68
Shares Outstanding (Diluted)	121	120	115	110	104	68
Shares Change (YoY)	1.06%	3.77%	5.15%	5.93%	52.00%	206.74%
EPS (Basic)	-0.04	-0.03	-0.03	-0.02	-0.03	-0.01
EPS (Diluted)	-0.04	-0.03	-0.03	-0.02	-0.03	-0.01
Free Cash Flow	-2.36	-2.43	-2.12	-1.62	-2.45	-0.09
Free Cash Flow Per Share	-0.02	-0.02	-0.02	-0.01	-0.02	-0.00
EBITDA	-2.79	-2.23	-3.45	-2.04	-1.91	-0.56
D&A For EBITDA	0.09	0.13	0.12	0.1	0.1	0.08
EBIT	-2.88	-2.37	-3.56	-2.14	-2.01	-0.65

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.